GO:0005080 protein kinase C binding: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0005080 (protein kinase C binding) is a molecular function defined as binding to protein kinase C, a family of serine/threonine kinases.
PKC binding proteins include AKAP79, RACK1, and other scaffolds that regulate PKC localization and substrate specificity.
PKC binding is critical for diverse cellular processes such as cell proliferation, differentiation, and apoptosis.
Dysregulated PKC binding contributes to cancer, diabetes, and neurological disorders [3,6].
CRISPR knockout, knock-in, and overexpression models are essential to dissect PKC binding functions [1,4].
EDITGENE provides custom cell models and screening services to study PKC binding in disease contexts.

Description

Protein kinase C (PKC) binding (GO:0005080) is a molecular function that mediates the interaction of proteins with PKC isoenzymes. This binding is fundamental for PKC signaling, influencing its subcellular localization, substrate accessibility, and downstream effects [2,7]. Researchers study PKC binding to understand how cells translate external signals into physiological responses, including proliferation, differentiation, and apoptosis. The QuickGO definition states that this term encompasses binding to any protein kinase C family member, with synonyms such as PKC alpha binding and PKC delta binding. Given the broad roles of PKC in health and disease, elucidating PKC binding mechanisms is crucial for identifying therapeutic targets.

protein kinase C binding At A Glance

GO ID GO:0005080
GO term protein kinase C binding
Ontology molecular_function
Synonym PKC alpha binding, PKC binding, PKC delta binding, PKC eta binding, protein kinase C alpha binding, protein kinase C delta binding, protein kinase C eta binding
Major function Binding to protein kinase C enzymes, regulating their localization and activity
Definition Binding to protein kinase C.
Related processes Signal transduction, cell proliferation, differentiation, apoptosis
Disease relevance Cancer, diabetes, neurological disorders

What Is GO:0005080?

GO:0005080 describes the molecular function of selectively interacting with protein kinase C (PKC) enzymes. This binding can be direct or indirect, often involving scaffolding proteins that anchor PKC to specific cellular compartments. The term includes binding to various PKC isoforms, such as PKC alpha, delta, and eta, and is essential for PKC-mediated signal transduction [2,7].

Why Is protein kinase C binding Important in Cell Biology?

PKC binding is a central node in cellular signaling, as it determines where and when PKC acts. Disruption of PKC binding can lead to aberrant signaling, contributing to diseases such as cancer and diabetes [3,6]. Understanding these interactions provides insights into drug development and precision medicine.
Regulates PKC substrate specificity and cellular responses.
Involved in cancer progression, including non-small-cell lung cancer.
Modulates immune cell development, such as NKT cells.
Affects ceramide signaling in renal mesangial cells.
Plays a role in calreticulin posttranslational modifications.
Contributes to membrane recruitment and polarization of atypical PKC.
Target for therapeutic intervention in inflammatory diseases.
Essential for understanding viral entry mechanisms, e.g., RSV.
Key to neuronal signaling and synaptic plasticity.
Provides a basis for CRISPR-based functional studies [1,4].

Molecular Mechanism of protein kinase C binding

PKC Domain Structure and Binding Interfaces
In simple terms: PKC proteins have specific regions that allow other proteins to grab onto them.
PKC isoenzymes contain conserved domains, including C1 and C2 domains, which mediate lipid and protein interactions. The C1 domain binds diacylglycerol and phorbol esters, while the C2 domain binds calcium and phosphatidylserine. Binding proteins often interact with these domains or the kinase domain to modulate PKC activity [2,8].
Scaffold Proteins and Anchoring
In simple terms: Scaffold proteins hold PKC in place so it can work efficiently.
Scaffolding proteins such as AKAP79 bind PKC and anchor it to specific subcellular locations, enhancing substrate phosphorylation. This interaction is regulated by calcium/calmodulin, which can disrupt binding.
Lipid and Cofactor Requirements
In simple terms: PKC binding often needs lipids and calcium to happen.
PKC binding to phosphatidylserine is cooperative and essential for membrane recruitment. Ceramide selectively binds PKC-alpha and -delta, influencing their localization and activity [2,6].
Regulation by Phosphorylation and Second Messengers
In simple terms: PKC binding can be turned on or off by other molecules.
Phosphorylation of PKC or its binding partners can alter interaction affinity. Second messengers like calcium and diacylglycerol promote PKC membrane association and binding to targets.
Isoform-Specific Interactions
In simple terms: Different PKC types bind to different partners.
PKC isoforms (alpha, delta, eta, iota) exhibit distinct binding preferences. For example, PKC-iota promotes UBF1-ECT2 binding on ribosomal DNA in lung cancer cells.

Key Genes Involved in GO:0005080 protein kinase C binding

The following genes encode proteins that bind to PKC or are PKC isoforms themselves, playing key roles in signaling and disease.
GeneMajor RoleResearch Relevance
PRKCAPKC alpha isoform; binds ceramide and phosphatidylserineImplicated in cancer and diabetes
PRKCDPKC delta isoform; binds ceramideRegulates apoptosis and immune responses
PRKCZAtypical PKC zeta; involved in cell polarityStudied in membrane recruitment
AKAP79Scaffold protein that binds PKCRegulates PKC localization and signaling
RACK1Receptor for activated C kinaseGuides PKC substrate specificity
CALRCalreticulin; interacts with PKCModulates posttranslational modifications
IGF1RInsulin-like growth factor 1 receptor; binds PKCViral entry receptor for RSV
PRKCIPKC iota; promotes UBF1-ECT2 bindingDrives rRNA synthesis in lung cancer
UBF1Upstream binding factor 1; binds PKC iotaRibosomal DNA transcription
ECT2Epithelial cell transforming 2; binds PKC iotaCell division and cancer
PKDProtein kinase D; activated by PKCNKT cell development
CAMCalmodulin; regulates AKAP79-PKC interactionCalcium signaling
PSPhosphatidylserine; lipid binding partnerPKC membrane recruitment
CERCeramide; binds PKC alpha/deltaSphingolipid signaling
PRKCEPKC epsilon; binds various proteinsCardiac and neuronal functions
PRKCHPKC eta; binds specific targetsT cell signaling
PRKCQPKC theta; binds scaffoldsImmune synapse formation

How Is protein kinase C binding Regulated?

PKC binding is regulated by calcium/calmodulin, which can disrupt interactions such as AKAP79-PKC. Phosphorylation of PKC or its partners modulates binding affinity. Lipid cofactors like phosphatidylserine and ceramide enhance or inhibit binding in a isoform-specific manner [2,6]. Second messengers such as diacylglycerol promote membrane recruitment and subsequent binding events.

protein kinase C binding and Human Disease

GeneDisease / BiologyPotential Experimental Model
PRKCINon-small-cell lung cancerKnockout in A549 cells
PRKCADiabetic nephropathyPoint mutation in mesangial cells
PRKCDAutoimmune disordersKnock-in mouse models
IGF1RRSV infectionOverexpression in HEK293 cells
PKDNKT cell deficiencyKnockout in Jurkat cells
PKC Binding in Cancer
PKC binding proteins are often dysregulated in cancer. For instance, PKC iota promotes UBF1-ECT2 binding on ribosomal DNA, driving rRNA synthesis and transformed growth in non-small-cell lung cancer. Targeting these interactions could offer therapeutic strategies.
PKC Binding in Metabolic Disorders
Ceramide binding to PKC alpha and delta in renal mesangial cells is implicated in diabetic nephropathy. Selective ceramide binding modulates PKC activity, affecting cell survival and matrix production.
PKC Binding in Immune Regulation
Invariant TCR-triggered protein kinase D activation, downstream of PKC binding, mediates NKT cell development. Disruption of this pathway can lead to immune deficiencies.
PKC Binding in Viral Infection
IGF1R, a PKC binding partner, serves as an entry receptor for respiratory syncytial virus (RSV). PKC binding may influence viral entry and pathogenesis.

From protein kinase C binding-Related Genes to Experimental Models

Research QuestionSuitable Model
Does PKC binding regulate cancer cell proliferation?CRISPR knockout of PRKCI in lung cancer cells
How does ceramide binding affect PKC localization?Point mutation of PRKCA ceramide-binding domain
Can PKC binding be visualized in live cells?Knock-in of fluorescent tags on PKC
What is the role of AKAP79-PKC interaction in neurons?Overexpression of AKAP79 mutants
Does PKC binding modulate immune cell development?Knockout of PKD in NKT cells
How does IGF1R-PKC binding affect viral entry?Overexpression of IGF1R in RSV models

How to Study the protein kinase C binding Process

MethodWhat It MeasuresTypical Application
Co-IP/MSProtein-protein interactionsIdentify novel PKC binding partners
FRETReal-time binding dynamicsVisualize PKC binding in live cells
CRISPR screenGene function in bindingDiscover regulators of PKC binding
Lipid binding assayAffinity for lipidsStudy phosphatidylserine binding
Kinase assayPKC activityMeasure effect of binding on catalysis
RNA-seqTranscriptional changesAssess downstream effects of PKC binding
Ribo-seqTranslation efficiencyLink PKC binding to protein synthesis
Proximity ligationIn situ interactionsDetect PKC binding in tissues
Proteomic Approaches
Co-immunoprecipitation coupled with mass spectrometry can identify novel PKC binding partners. This method reveals dynamic interactions under different conditions.
Imaging Techniques
Fluorescence resonance energy transfer (FRET) and live-cell imaging allow visualization of PKC binding in real time, providing spatiotemporal insights.
Genetic Screens
CRISPR library screens can identify genes that regulate PKC binding. This unbiased approach uncovers pathways affecting PKC localization and function.
Biochemical Assays
Lipid binding assays and kinase activity assays measure the impact of binding on PKC function. These are useful for validating interactions [2,6].

How CRISPR Can Be Used to Study GO:0005080 protein kinase C binding

Knockout

CRISPR knockout of genes encoding PKC binding proteins (e.g., PRKCI, AKAP79) can reveal their essential roles in signaling. For example, PRKCI knockout reduces rRNA synthesis in lung cancer cells.

Point Mutation

Introducing point mutations in PKC binding domains (e.g., ceramide-binding site of PRKCA) allows precise dissection of binding contributions without affecting other functions.

Knock-in

Knock-in of epitope tags or fluorescent proteins into endogenous PKC genes enables tracking of binding dynamics and localization in real time.

Overexpression

Overexpression of PKC binding proteins or mutants can amplify signaling pathways, useful for studying gain-of-function effects in disease models.

How EDITGENE Supports protein kinase C binding Research

Researchers studying protein kinase C binding-related genes often need to determine whether a candidate gene is causally involved in a specific signaling pathway or disease. EDITGENE provides custom CRISPR cell models and screening services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for protein kinase C binding research.

Frequently Asked Questions About protein kinase C binding

Protein kinase C binding (GO:0005080) is a molecular function where a protein interacts with PKC enzymes, regulating their activity and localization.
Genes include PRKCA, PRKCD, PRKCI, AKAP79, RACK1, and others that encode PKC isoforms or binding partners [3,7].
It determines where PKC acts, influencing substrate phosphorylation and downstream pathways like proliferation and apoptosis.
Cancer, diabetic nephropathy, immune disorders, and viral infections [1,3,4,6].
Co-IP, FRET, CRISPR screens, and biochemical assays [2,7,8].
Yes, knockout, knock-in, and point mutation models help dissect binding functions [1,3,4].
PKC iota promotes UBF1-ECT2 binding on ribosomal DNA, driving rRNA synthesis in lung cancer.
By calcium/calmodulin, phosphorylation, and lipid cofactors like phosphatidylserine and ceramide [2,6,7].
PKC alpha binding, PKC binding, PKC delta binding, PKC eta binding, and others.
It offers targets for modulating PKC signaling in diseases like cancer and diabetes [3,6].

Conclusion

Protein kinase C binding (GO:0005080) is a pivotal molecular function that orchestrates diverse signaling pathways. Understanding its mechanisms and regulation is essential for developing targeted therapies. EDITGENE's CRISPR services empower researchers to explore PKC binding in health and disease.

References

  1. 1. Griffiths CD et al.. 2020. IGF1R is an entry receptor for respiratory syncytial virus.. Nature 583(7817):615-619 PMID: 32494007
  2. 2. Orr JW et al.. 1992. Interaction of protein kinase C with phosphatidylserine. 1. Cooperativity in lipid binding.. Biochemistry 31(19):4661-7 PMID: 1581316
  3. 3. Justilien V et al.. 2020. Protein kinase Cι promotes UBF1-ECT2 binding on ribosomal DNA to drive rRNA synthesis and transformed growth of non-small-cell lung cancer cells.. J Biol Chem 295(24):8214-8226 PMID: 32350115
  4. 4. Ishikawa E et al.. 2025. Invariant TCR-triggered protein kinase D activation mediates NKT cell development.. J Exp Med 222(12) PMID: 40965511
  5. 5. Cristina Castañeda-Patlán M et al.. 2010. Protein kinase C is involved in the regulation of several calreticulin posttranslational modifications.. Int J Biochem Cell Biol 42(1):120-31 PMID: 19800981
  6. 6. Huwiler A et al.. 1998. Selective ceramide binding to protein kinase C-alpha and -delta isoenzymes in renal mesangial cells.. Biochemistry 37(41):14556-62 PMID: 9772184
  7. 7. Faux MC et al.. 1997. Regulation of the AKAP79-protein kinase C interaction by Ca2+/Calmodulin.. J Biol Chem 272(27):17038-44 PMID: 9202019
  8. 8. Jones KA et al.. 2023. Cooperative regulation of C1-domain membrane recruitment polarizes atypical protein kinase C.. J Cell Biol 222(10) PMID: 37589718
Contact Us
*
*
*
*
How did you hear about us: